These will induce a highly immunosuppressive tumor microenvironment (TME) by promoting the expression of the inhibitory molecule PD-L1, the expansion of tumor-associated macrophages (TAMs), the increase in PGE2 production and an aberrant metabolism of glycosaminoglycans [16]. The gene discussed is CD274; the disease is neoplasm.